Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
August 14, 2024 07:40 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 14 August 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Novo Nordisk A/S – Share repurchase programme
August 12, 2024 08:31 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 12 August 2024 – On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
August 12, 2024 08:04 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 12 August 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
August 09, 2024 14:29 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 9 August 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
August 08, 2024 12:54 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 8 August 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Novo Nordisk's sales increased by 24% in Danish kroner and by 25% at constant exchange rates to DKK 133.4 billion in the first six months of 2024
August 07, 2024 01:31 ET
|
Novo Nordisk A/S
Bagsværd, 7 August 2024 - Financial report for the period 1 January 2024 to 30 June 2024Operating profit increased by 18% in Danish kroner and by 19% at constant exchange rates (CER) to DKK 57.8...
Novo Nordisk A/S - share repurchase programme
August 06, 2024 07:15 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 06 August 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of...
Novo Nordisk A/S – Share repurchase programme
July 29, 2024 07:05 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 29 July 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16...
European regulatory authority adopts a positive opinion for an update of the Wegovy® label to reflect risk reduction of major adverse cardiovascular events
July 25, 2024 11:08 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 25 July 2024 – Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an...
Novo Nordisk A/S - share repurchase programme
July 22, 2024 08:22 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 22 July 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16...